首页> 外文期刊>Journal of Medicinal Chemistry >Nuclear Factor-KB Mediated Inhibition of Cytokine Production by Imidazoline Scaffolds
【24h】

Nuclear Factor-KB Mediated Inhibition of Cytokine Production by Imidazoline Scaffolds

机译:核因子-KB介导的咪唑啉支架抑制细胞因子的产生。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The mammalian nuclear transcription factor NF-kB is responsible for the transcription of multiple cytokines, including the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin 6 (IL-6). Elevated levels of pro-inflammatory cytokines play an important role in the pathogenesis of inflammatory disorders such as rheumatoid arthritis (RA). Inhibition of the pro-inflammatory transcription factor NF-KB has therefore been identified as a possible therapeutic treatment for RA. We describe herein the synthesis and biological activity of a series of imidazoline-based scaffolds as potent inhibitors of NF-kB mediated gene transcription in cell culture as well as inhibitors of TNF-α and IL-6 production in interleukin 1 beta (IL-1β) stimulated human blood.
机译:哺乳动物核转录因子NF-kB负责多种细胞因子的转录,包括促炎性细胞因子肿瘤坏死因子α(TNF-α)和白介素6(IL-6)。促炎细胞因子水平升高在诸如类风湿性关节炎(RA)的炎性疾病的发病机理中起重要作用。因此,已确认抑制促炎性转录因子NF-KB是RA的可能治疗方法。我们在本文中描述了一系列咪唑啉基支架的合成和生物学活性,这些支架是细胞培养中NF-kB介导的基因转录的有效抑制剂,以及白介素1 beta(IL-1β)中的TNF-α和IL-6产生的抑制剂)刺激了人体血液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号